Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 3, Issue 1, 2009, Pages 4-7

  Bossuyt, Peter ^a   Verhaegen, Jan ^a   Van Assche, Gert ^a   Rutgeerts, Paul ^a   Vermeire, Séverine ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Clostridium difficile; Immunomodulators; Inflamamatory bowel disease; Post antibiotic diarrhea; Ribotype NAP1 027

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOMODULATING AGENT; METRONIDAZOLE; ORNIDAZOLE; PROTON PUMP INHIBITOR; STEROID; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CONCURRENT INFECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENTERITIS; FECES ANALYSIS; FEMALE; GASTROENTEROLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT DURATION; ULCERATIVE COLITIS;

EID: 58849083648     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.09.003     Document Type: Article

References (21)

1. Durai R. Epidemiology, pathogenesis, and management of Clostridium difficile infection. Dig Dis Sci 52 (2007) 2958-2962
2. Kuipers E., and Surawicz C. Clostridium difficile infection. Lancet 371 (2008) 1486-1488
3. Monaghan T., Boswell T., and Mahida Y.R. Recent advances in Clostridium difficile-associated disease. Gut 57 (2008) 850-860
4. Bartlett J. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 46 suppl 1 (2008) S4-S11
5. Kuijper E.J., van Dissel J.T., and Wilcox M.H. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis Aug 20 (2007) 376-383
6. McDonald L., Owings M., and Jemigan D. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 34 (2006) 346-353
7. McFarland L. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5 (2008) 40-48
8. Dobson R. Report names hospitals with highest proportions of deaths related to MRSA and C. difficile. BMJ 336 (2008) 1211
9. Seppälä K., Hjelt L., and Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. Scand J Gastroenterol 16 (1981) 465-468
10. Pépin J., Valiquette L., and Alary M.E. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
11. Delmée M. Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7 (2001) 411-416
12. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
13. Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., and Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 339-344
14. Issa M., Vijayapal A., Graham M.B., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 345-351
15. Nguyen G.C., Kaplan G.G., Harris M.L., and Brant S.R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 103 (2008) 1443-1450
16. Lundeen S., Otterson M., Binion D., Carman E., and Peppard W. Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg 11 (2007) 138-142
17. Zar F., Bakkanagari S., Moorthi K., and Davis M. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45 (2007) 302-307
18. Sunenshine R.H., and McDonald L.C. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 14 (2006) 187-197
19. Issa M., Ananthakrishnan A.N., and Binion D.G. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 14 (2008) 1432-1442
20. Ananthakrishnan A., McGinley E., and Binion D. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57 (2008) 205-210
21. Toruner M., Loftus Jr. E.V., Harmsen W.S., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134 (2008) 929-936